Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Aslam Shaikh’s Malad Masti Ignites Community Spirit in Mumbai Business
  • Skin Aesthete by Dr. Sonal Ahuja Turns 1, Unveils Two New Innovations in Luxury Skincare Health
  • Surat’s First Event Conclave: A Bold Leap That Could Ignite Innovation in Event Industry Business
  • Vani Prakashan Heralds Dharamvir Bharati’s Centenary With Star-Studded Fest Lifestyle
  • Simmi Saboo Returns Heart and Soul to Contemporary Indian wear in an Era of Fast Fashion Lifestyle
  • Skyexch.net to be the title partner of the SLC Invitational T20 League 2022 Press Release
  • Celebrate the Indian Republic by trying vegan this January Business
  • Deepak Balutia’s Journey as a Politician – from a Secretary to a Spokesperson Press Release

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Protecting from Risk of Heart Failure, Cardiac Arrest and Stroke Calls for Preventive Screening whether Covid or Non-Covid Health
  • Dentium to host the World’s Largest Dental Seminar in Delhi  on 21st April 2024 Health
  • Doctor’s Day Special: Experts Advice To Take Care of Your Health Health
  • Addressing The Alarming Increase In Myopia Globally, Ojas Eye Hospital Offers Elita Silk, A Revolutionary Vision Correction Procedure In Western India Health
  • Centre for Sight and Milind Soman Urge India to Prioritize Eye Health on World Senior Citizen’s Day Health
  • Doctors Don’t Know Everything : Dr. Lingaraj Nath’s Guide to Navigating Modern Healthcare with Self Health & Empowerment Health

Recent Posts

  • Manasi Pawar Makes a Jaw-Dropping Red Carpet Debut at the 2026 Cannes Film Festival
  • German Trade Fair Leader Messe Stuttgart Strengthens Presence in India with Acquisition of ‘Cable & Wire Fair’
  • How to Protect Your Savings from Inflation: The Power of Compounding Explained
  • WebyStrata: Reseller Hosting Provider in India for Agencies, Developers, and Businesses
  • MBA in India: Elite Business Schools and the Admissions Journey in 2026

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Shah Metacorp Ltd Net Profit jump to Rs. 23.27 Crore in Q1FY25 Business
  • Briyo: Beyond Business – A Journey of Impact, Quality, and Growth Business
  • Future business positive as huge orders booked at Ind-Texpo 2022 Business
  • HospitalityNews Presents: Your Talent, Our Stage – Enter the Limelight Now Business
  • Siddha-Sejal Group receives OC for ‘Siddha Seabrook’, its first premium project in Mumbai Business
  • IITIAN GUIDE – Revolutionizing Online IIT-JEE Coaching in INDIA and Internationally through Emotional Support to Students Press Release
  • Key Benefits of Opening Demat Account with SMC Global Securities Finance
  • Supreme Power Equipment Limited Marks Entry into Maharashtra with ₹13.50 Cr Transformer Order Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme